Psoriasis patient’s mental health is more than skin-deep

 

Umeå, Sweden (June 4, 2020) — Treatment of the common disease psoriasis, usually focuses on treating the skin. However, psoriasis patients often have other physical diseases that can bring on depression, anxiety, and suicide. A new study from Umeå University, Sweden, shows that these other somatic diseases have even more impact on patients’ mental health than their skin symptoms, highlighting the importance of holistic patient care.

Psoriasis is a lifelong disease. The body produces skin cells too quickly which build up on the skin’s surface in the form of inflamed red, painful, itchy scales. Many people with psoriasis have other physical diseases such as being overweight, diabetes and heart diseases.

“What we didn’t know before is how psoriasis skin symptoms and other somatic diseases associated with psoriasis impact mental health,” says Marcus Schmitt-Egenolf, Dermatologist and Professor at Umeå University.

Previous research found that people with psoriasis suffer more often from somatic and mental diseases compared to individuals without psoriasis. A new study confirmed this. The study also investigated how psoriasis skin symptoms and associated somatic diseases impacted mental health, considering anxiety, depression and suicide together.

The study found that skin symptoms have an important impact on mental health, but that other somatic diseases associated with psoriasis can cause even more harm to mental health.

“We found that skin symptoms increased the risk of mental illness by a third, while other physical illnesses doubled the risk among psoriasis patients,” says Kirk Geale, PhD candidate at Umeå University. The results in the study shows a 32 percent increase risk of mental illness caused by skin symptoms and a 109 percent increased risk at other somatic illnesses.

This information is important as the total burden of mental health burden for people with psoriasis, and what contributes to it, was not well established. The study’s findings encourage people with psoriasis to talk with their doctors more about symptoms beyond the skin, both physical and mental. It also encourages doctors to proactively discuss these issues with their patients.

“I would be delighted if our study could support the trend towards a more holistic view on psoriasis care. At the doctor’s office, lifestyle factors should be discussed in the awareness that individual responsiblity may be limited by available personal and community resources. Such an approach may improve the complete triad of psoriasis – skin symptoms, somatic and mental health alike,” concludes Marcus Schmitt-Egenolf.

The study was conducted during 2017 – 2019. Nationwide data from about 100.000 individuals with psoriasis but without earlier mental diseases in Sweden were compared to a control group without psoriasis. The study is published in JAMA Dermatology.

 


Umea University, 20.04.2020 (tB).

Schlagwörter: , ,

MEDICAL NEWS

Inadequate sequencing of SARS-CoV-2 variants impedes global response to COVID-19
New meta-analysis finds cannabis may be linked to development of…
New guidance on how to diagnosis and manage osteoporosis in…
Starting the day off with chocolate could have unexpected benefits
Better mental health supports for nurses needed, study finds

SCHMERZ PAINCARE

Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…
Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern

DIABETES

„Wissen was bei Diabetes zählt: Gesünder unter 7 PLUS“ gibt…
Toujeo® bei Typ-1-Diabetes: Weniger schwere Hypoglykämien und weniger Ketoazidosen 
Bundestag berät über DMP Adipositas: DDG begrüßt dies als Teil…
Mit der Smartwatch Insulinbildung steuern
Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…

ERNÄHRUNG

Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren

ONKOLOGIE

Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver
Positive Ergebnisse beim fortgeschrittenen Prostatakarzinom: Phase-III-Studie zur Radioligandentherapie mit 177Lu-PSMA-617
Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!
Deutsch-dänisches Interreg-Projekt: Grenzübergreifende Fortbildungskurse in der onkologischen Pflege
Sotorasib: Neues Medikament macht Lungenkrebs-Patienten Hoffnung

MULTIPLE SKLEROSE

NMOSD-Erkrankungen: Zulassung von Satralizumab zur Behandlung von Jugendlichen und Erwachsenen
Verzögerte Verfügbarkeit von Ofatumumab (Kesimpta®)
Neuer Biomarker bei Multipler Sklerose ermöglicht frühe Risikoeinschätzung und gezielte…
Multiple Sklerose beginnt oft lange vor der Diagnose
Goldstandard für Versorgung bei Multipler Sklerose

PARKINSON

Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung